Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Howard

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2025
Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extensionVallerie V McLaughlin, Luke Howard, Jean Elwing, et al.
The Lancet. Respiratory Medicine|November 20, 2020
Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19Ranju T Dhawan, Deepa Gopalan, Luke Howard, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2010
Simvastatin as a treatment for pulmonary hypertension trialMartin R Wilkins, Omar Ali, William Bradlow, et al.
Pulmonary Circulation|March 13, 2014
Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial functionHilda Tsang, James Leiper, Ka Hou Lao, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 5, 2020
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial HypertensionDavide Stolfo, Stefano Albani, Federico Biondi, et al.
ERJ Open Research|July 9, 2024
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in EuropeDavid Montani, José M Cifrián, Raquel P Rojo, et al.
Cardiovascular Research|April 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transportBin Liu, Mujahid Azfar, Ekaterina Legchenko, et al.
Experimental Lung Research|November 17, 2010
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertensionIvan M Robbins, Anna R Hemnes, J Simon Gibbs, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of LifeKatherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3Katherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2025
Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extensionVallerie V McLaughlin, Luke Howard, Jean Elwing, et al.
The Lancet. Respiratory Medicine|November 20, 2020
Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19Ranju T Dhawan, Deepa Gopalan, Luke Howard, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2010
Simvastatin as a treatment for pulmonary hypertension trialMartin R Wilkins, Omar Ali, William Bradlow, et al.
Pulmonary Circulation|March 13, 2014
Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial functionHilda Tsang, James Leiper, Ka Hou Lao, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 5, 2020
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial HypertensionDavide Stolfo, Stefano Albani, Federico Biondi, et al.
ERJ Open Research|July 9, 2024
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in EuropeDavid Montani, José M Cifrián, Raquel P Rojo, et al.
Cardiovascular Research|April 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transportBin Liu, Mujahid Azfar, Ekaterina Legchenko, et al.
Experimental Lung Research|November 17, 2010
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertensionIvan M Robbins, Anna R Hemnes, J Simon Gibbs, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of LifeKatherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3Katherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Pageof 10